SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as the community rallies around its decentralized nature and potential Coinbase listing, emphasizing its strong fundamentals within the Bitcoin ecosystem. Community members highlight its fair launch and organic growth, positioning it as the premier meme coin on Bitcoin. The focus remains on its unique status compared to other meme coins.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid growing excitement around biometric software deployments at international airports and speculation regarding new government contracts. The community is actively discussing potential short squeezes and drawing comparisons to $PLTR, highlighting the company's AI-driven security solutions. Bullish investors are focusing on positive chart patterns and anticipating significant gains.

Slopana

Slopana is trending as community members rally around the Solana-based meme coin, referring to it as digital slop and Solana's mascot. Conversations highlight the strong community, a doxxed CTO, and the coin's availability on Phantom Wallet. Many believe Slopana has the potential for significant growth within the Solana ecosystem, with some drawing parallels to other successful meme coins.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as the company promotes its Mars Telecommunications Orbiter (MTO) concept, envisioning a crucial communication link for future Mars missions, and the community speculates about potential acquisitions. Discussions also revolve around a potential stock offering and its implications for funding growth initiatives, acquisitions, and Neutron rocket development. Bullish sentiment remains, with many anticipating a rise in share price despite potential short-term volatility.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is trending after a massive spike, driven by news of a potential $500M funding round to launch a SOL-backed treasury vehicle, sparking excitement about a shift towards blockchain innovation. The community is closely watching key resistance levels and debating whether the stock can sustain its momentum or retrace. Some traders are comparing it to other recent low-float runners and anticipating further volatility.

WEBTOON Entertainment, Inc. engages in the provision of global storytelling platform. The firm offers creators and users to discover, create, and share new content. Its brands include Munpia, Yonder, Studio Lico, LINE, and Creator Studios. The company was founded by Jun-Koo Kim in 2005 and is headquartered in Los Angeles, CA.

Webtoon Entertainment Inc.

Webtoon Entertainment Inc

Webtoon Entertainment ($WBTN) is trending after a significant after-hours surge, reportedly fueled by deepening ties with Disney to create a new digital comics platform and Disney acquiring a 2% equity stake. The community is actively discussing the potential for a continued run, high short interest, and low float, while also weighing the speculative nature of the non-binding term sheet. Some traders suggest watching key support levels and lower H% entries.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community discusses Elon Musk's recent $1 billion stock purchase and its potential impact. Bullish investors view this as a vote of confidence and anticipate further gains, while bears remain skeptical, citing valuation concerns and broader market factors. Some traders are also closely watching for news related to potential Fed interest rate cuts and their implications for Tesla.

Daifuku is a real Shiba Inu dog in based in Japan. Daifuku is well loved and recognized globally being the star of many memes and photos/videos. Daifuku is a community driven project with brand recognition. Daifuku also serves to teach the lessons of decentralization and treating each other respectfully. Daifuku was rugged and true colors showed, the Daifuku community has come for their revenge. Community participation and empowerment while also paying respect to a famous Shiba Inu. Daifuku will provide that much needed integrity and transparency in the industry.

DAIFUKU

DAIFUKU.X is trending due to community-driven initiatives focused on building a decentralized brand honoring a Shiba Inu named Daifuku. The community aims to support Daifuku and his owners through various projects, fostering a sense of ownership and shared vision within the Shiba Inu ecosystem. Comparisons to other decentralized projects like SHIB and BONE are circulating as the community rallies around this token.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

OKLO is trending due to growing interest in its potential role in powering AI data centers and a recent analyst upgrade, fueling speculation despite its pre-revenue status. The community is actively discussing the stock's high valuation and future prospects in the nuclear energy sector, with some eyeing triple-digit price targets. Investors are weighing the long-term potential against near-term risks, contributing to significant price volatility.

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

NanoVibronix Inc

NanoVibronix is trending following a large move upwards, reportedly fueled by a recently granted U.S. patent for its ENvue Medical subsidiary, with many traders eyeing the low float and potential for further gains. Community members are actively discussing key resistance and support levels, as well as potential price targets, while some caution against chasing the stock after the significant surge. The stock's momentum has drawn comparisons to other recent low-float runners in the market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Medical Stocks Lagging  AxoGen (AXGN) This Year?

Here is how AxoGen (AXGN) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect?

The mean of analysts' price targets for AxoGen (AXGN) points to a 53.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Axogen, Inc. (AXGN) announced on Monday that the U.S. Food and Drug Administration (FDA) has postponed the date by which it would decide on the company’s application requesting approval for Avance Nerve Graft.Shares of the company tumbled 15% in Monday’s pre-market session after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.axogeninc.com/press-releases/detail/1007/axogen-provides-update-on-fda-review-timeline-for-avance">announced</a> that the agency pushed the date of the decision by three months to Dec. 5, 2025. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves.An "off-the-shelf" processed human nerve allograft is a biologically active implant made from donated human nerve tissue that is surgically treated to remove cellular and non-cellular debris, preserving the native nerve's structural integrity. Unlike traditional autografts, allografts are "off-the-shelf," meaning they are immediately available for surgical use.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AXGN">AXGN stock</a> fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours while message volume remained at ‘low’ levels.The company said that it received communication from the FDA on August 22, indicating that the information it submitted in response to an FDA information request was deemed a major amendment to its initial application filed in September 2024 and accepted by the agency in November. The company submitted fresh data, including substantial new manufacturing and facility data, in response to the request.FDA subsequently extended the date for making its decision, allowing for additional time to review the submission. The FDA also told the company that it now expects to provide feedback on product labelling in November.CEO Michael Dale said that the company looks forward to continuing engagement with the FDA to get Avance approved.AXGN stock is down by 1% this year but up by about 28% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-slides-to-july-levels-ethereum-retreats-from-weekend-highs/chssNkNRd1i">Bitcoin Slides To July Levels, Ethereum Retreats From Weekend Highs – $840M Liquidated In Crypto Selloff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Why Is Axogen Stock Down 15% In Pre-Market Today?

Axogen stock tumbled after the company announced that the U.S. FDA pushed the date of the decision regarding approval for Avance Nerve Graft by three months.

Equity

The stock tumbled after the company announced that the U.S. FDA pushed the date of the decision regarding approval for Avance Nerve Graft by three months.


Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 76.4% in AxoGen (AXGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of +0.68% and +3.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know

PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?

AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AxoGen Q2 Earnings and Revenues Beat Estimates

AxoGen (NASDAQ: AXGN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to loss of $0.03 per share a year ago...

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Axogen Inc.

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

AXGN
Axogen Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AXGN News

AXGN Axogen Inc.